Erratum to: Derivation of tunneling probabilities for arbitrarily graded potential barriers using modified Airy functionsTunneling probabilityGraded potential barrierWKB methodModified Airy functionsErratum to: Opt Quant Electron (2010) 42:129–141 DOI 10.1007/s11082-010-9434-7 The authors would like to ...
Lippmann et al. present a protocol for differentiating human pluripotent stem cells into blood-brain barrier endothelial cells. The cells should be useful for studying this endothelial barrier, including screening for drugs that can cross from the blood
3. The mode of action (MoA) for carcinogenicity 4. Oral studies in mammals with specific emphasis on local irritation 5. Studies with oral exposure in birds, specific emphasis on local irritation (Table 1) 6. Studies with oral exposure, potential systemic effects 7. Reproductive and developmenta...
Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. The blood-brain barrier (BBB) is crucial to the health of the brain and is often compromised in neurological disease. Moreover, because of its barrier prop... ES Lippmann,SM Azarin,JE Kay,... - 《Nature...
Hobart [9] simulated the threshold potential of movement which was represented by the minimum energy difference between stable and unstable configurations of dislocation in the polycrystalline Cu. Graham [10] calculated the Peierls barrier through the addition of a non-harmonic potential in BCC (body...
Brain microvascular endothelial cells (BMECs) can be differentiated from human induced pluripotent stem cells (iPSCs) to develop ex vivo cellular models for studying blood-brain barrier (BBB) function. This modified protocol provides detailed steps to derive, expand, and cryopreserve BMECs from huma...
Application of TiO Photocatalysts to NO and SO Removal in Dielectric Barrier Discharge Process There is an additional erroneous assumption for the derivation of the Clausius-Clapeyron equation, related to the equality of chemical potentials of the two... A Nasonava,Dong-Joo Kim,Kyo-Seon Kim - ...
for the clinical use of PSCs lies within their ability to keep a stable genome and epigenome, such as the X-chromosome dosage compensation in humans which is deregulated in primed hPSCs after long-term culture and is therefore a potential barrier for regenerative medicine37. Combining knowledge ...
A major barrier to progress is the overly broad definition of the syndrome, which encompasses a vast, multidimensional array of clinical and biological features. Different combinations of these features may naturally cluster into previously undescribed subsets or phenotypes that may have different risks ...
Finally, although human feeder cells are currently the standard for mRNA reprogramming, even these cells are a potential source of xeno-biological contamination when non-human animal products are used in their derivation and expansion. We reasoned that the weaknesses inherent in current mRNA-based ...